Mark Jones

21PUBLICATIONS
91CO-AUTHORS
Instrumental methods (excl. immunological and bioassay methods)Immunogenetics (incl. genetic immunology)Environmental biogeochemistryRespiratory diseasesNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 13, 2026
Beneficial effects of the AT2 receptor agonist buloxibutid (C21) against acute alveolar epithelial cell inflammation during antiviral responses.

|May 05, 2026
Expanded detection of early fibrotic phenotypes using lobar traction bronchiolectasis in lung cancer screening.

|Sep 03, 2025
Air pollution and alveolar health.

Carmelo Sofia, James G H Parkin, Joseph A Bell

|Oct 01, 2024
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study.

Olivia C Leavy, Richard J Russell, Ewen M Harrison

|Jan 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK.

Giles Dixon, Samuel Hague, Sarah Mulholland

|Nov 16, 2023
Mortality surrogates in combined pulmonary fibrosis and emphysema.

An Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc

Pageof 4

Frequent Collaborators

7 joint publications

Joseph Jacob

6 joint publications

Christopher J Brereton

5 joint publications

Donna E Davies

5 joint publications

Yihua Wang